KPRX SCHEDULE 13G/A: SEC filing

Alyeska Investment Group

Filed with the SEC on · accession 0001172661-26-005391

KPRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Alyeska Investment Group filed an amended Schedule 13G disclosing beneficial ownership of 220,776 shares of Kiora Pharmaceuticals (4.99%) issuable upon exercise of warrants, subject to a 4.99% beneficial ownership blocker. The stock moved -20.2% by the first close after the filing.

Summary of the filing

Alyeska Investment Group filed an amended Schedule 13G disclosing beneficial ownership of 220,776 shares of Kiora Pharmaceuticals (4.99%) issuable upon exercise of warrants, subject to a 4.99% beneficial ownership blocker. The filing is a passive investment disclosure with no intent to influence control.

Key details

Shares of common stock beneficially owned (issuable upon exercise of warrants)$221K
Warrants exercisable for shares of common stock (subject to 4.99% blocker)$597K
Total shares of common stock outstanding$4.4M
Reporting person / investment managerAlyeska Investment Group, L.P.
Reporting personAlyeska Fund GP, LLC
Holder of the securitiesAlyeska Master Fund, L.P.
IssuerKiora Pharmaceuticals, Inc.
Chief executive officer, alyeska investment group, l.p.Anand Parekh
Chief financial officer, alyeska investment group, l.p.Jason Bragg

How KPRX stock reacted

Close before

$1.23

Nov 13, 2026

First close after

-20.16%

$0.98

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for KPRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for KPRX?

Click here

Frequently asked questions

What did KPRX file with the SEC on Nov 16, 2026?

KPRX filed a SCHEDULE 13G/A (SEC filing). Alyeska Investment Group filed an amended Schedule 13G disclosing beneficial ownership of 220,776 shares of Kiora Pharmaceuticals (4.99%) issuable upon exercise of warrants, subject to a 4.99% beneficial ownership blocker. The filing is a passive investment disclosure with no intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did KPRX stock react to this filing?

KPRX closed at $1.23 before the filing and $0.98 on Nov 16, 2026 (-20.16%).

Other KPRX SEC filings

Get alerts when KPRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days